Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of targeted therapies where bromoacetyl functionality enables conjugation to biomolecules. Its structure supports the creation of covalent inhibitors by allowing attachment to specific protein sites. Also employed in research settings for labeling and cross-linking studies due to the reactive bromo group. Suitable for modifying peptides or small molecules to enhance binding affinity or stability in drug design.